ValueInvest Asset Management’s Pfizer PFE Stock Holding History

ValueInvest Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$154M	Sell	4,562,555 -17,180	-0.4%	-$591K	10.46%	5
2017 Q4	$157M	Buy	4,579,735 +125,742	+3%	+$4.29M	9.73%	6
2017 Q3	$151M	Buy	4,453,993 +28,247	+0.6%	+$908K	10.05%	6
2017 Q2	$141M	Buy	4,425,746 +394,091	+10%	+$12.4M	8.71%	6
2017 Q1	$131M	Buy	4,031,655 +121,420	+3%	+$3.83M	7.94%	6
2016 Q4	$120M	Buy	+3,910,235	New	+$119M	7.24%	8

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ValueInvest Asset Management's PFE Position: Q1 2018 in Review

ValueInvest Asset Management reduced its Pfizer (PFE) stake by 0.38% in Q1 2018, selling an estimated $591K and leaving 4,562,555 shares worth $154M. The position accounts for 10.46% of the portfolio, ranked #5.

ValueInvest Asset Management first reported a position in PFE in Q4 2016 and has held it in 6 quarters since. The position peaked at $157M in Q4 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

ValueInvest Asset Management held 4,562,555 shares of Pfizer worth $154M as of Q1 2018.
ValueInvest Asset Management sold 17,180 Pfizer shares in Q1 2018, an estimated $591K.
Pfizer made up 10.46% of ValueInvest Asset Management's portfolio in Q1 2018, its #5 holding.
ValueInvest Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 6 quarters since.
ValueInvest Asset Management's Pfizer position peaked at $157M in Q4 2017.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on ValueInvest Asset Management's 13F filing for Q1 2018, filed 9 May 2018.